Phathom Pharmaceuticals, Inc.PHATNASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending lower, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-266.90M
↓ 123% below average
Average (6y)
$-119.43M
Historical baseline
Range
High:$-1.02M
Low:$-266.90M
CAGR
+152.8%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-266.90M | -91.7% |
| 2023 | $-139.21M | +5.7% |
| 2022 | $-147.57M | +0.8% |
| 2021 | $-148.78M | -110.4% |
| 2020 | $-70.73M | -14.5% |
| 2019 | $-61.76M | -5937.1% |
| 2018 | $-1.02M | - |